BioMarin Pharmaceutical Inc. buy The Goldman Sachs Group, Inc.
Start price
05.05.25
/
50%
€54.86
Target price
05.05.26
€91.75
Performance (%)
-16.95%
End price
06.05.26
€45.56
Summary
This prediction ended on 06.05.26 with a price of €45.56. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.95%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 2.356% | 2.356% | 5.452% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $124.00 to $104.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten